Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 1/20 | 0.64 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.64 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.64 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.57 |
| ▸ | CTSB | P07858 | 2/20 | 0.57 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.56 |
| ▸ | NMBR | P28336 | 2/20 | 0.55 |
| ▸ | GRPR | P30550 | 2/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.51 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.50 |
| ▸ | DPP3 | Q9NY33 | 4/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.49 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSK | P43235 | 2/20 | 0.48 |
| ▸ | CTSH | P09668 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30518080 | 0.95 | NTSR2 (0.65) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL31105546 | 0.93 | CAPN1 (0.58) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30518116 | 0.89 | NTSR2 (0.58) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30974182 | 0.88 | NTSR2 (0.70) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30608996 | 0.87 | CAPN1 (0.58) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30605453 | 0.84 | NMBR (0.59) | NTSR2NTSR1SORT1C5AR1NMBR | |
| SCHEMBL31105525 | 0.84 | C5AR1 (0.58) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30769646 | 0.84 | NTSR2 (0.65) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30123592 | 0.83 | GRPR (0.57) | NTSR2NTSR1SORT1C5AR1NMBR | |
| SCHEMBL31404231 | 0.82 | CAPN1 (0.59) | NTSR2NTSR1SORT1CAPN1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| CN-117343140-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | ARGLU1, ARG1, POT1 | NTSR2 2409/4885NTSR1 1700/4885SORT1 3901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.